Technical Analysis for DOVA - Dova Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 30.9 1.15% 0.35
DOVA closed up 1.15 percent on Friday, January 19, 2018, on 1.5 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
0 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical DOVA trend table...

Date Alert Name Type % Chg
Jan 19 Doji - Bearish? Reversal 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 19 Overbought Stochastic Strength 0.00%
Jan 19 Up 3 Days in a Row Strength 0.00%
Jan 19 Upper Bollinger Band Touch Strength 0.00%
Jan 18 Multiple of Ten Bullish Other 1.15%
Jan 18 Wide Bands Range Expansion 1.15%
Jan 18 Overbought Stochastic Strength 1.15%
Jan 18 Upper Bollinger Band Touch Strength 1.15%
Jan 17 Stochastic Reached Overbought Strength 2.25%

Older signals for DOVA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocytopenia in patients with chronic liver disease (CLD). The Company’s product candidate, avatrombopag is an orally administered thrombopoietin receptor agonist, or TPO-RA. The Company has completed pivotal Phase 3 clinical trials that evaluated avatrombopag for the treatment of thrombocytopenia in patients with CLD. The Company has not generated any revenue.
Is DOVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.75
52 Week Low 16.98
Average Volume 92,305
200-Day Moving Average 0.0
50-Day Moving Average 28.3092
20-Day Moving Average 28.9405
10-Day Moving Average 29.744
Average True Range 1.6955
ADX 13.65
+DI 17.02
-DI 20.56
Chandelier Exit (Long, 3 ATRs ) 27.4135
Chandelier Exit (Short, 3 ATRs ) 30.7165
Upper Bollinger Band 31.3172
Lower Bollinger Band 26.5638
Percent B (%b) 0.91
BandWidth 16.424734
MACD Line 0.4561
MACD Signal Line 0.2649
MACD Histogram 0.1912
Fundamentals Value
Market Cap 792.65 Million
Num Shares 25.7 Million
EPS -2.09
Price-to-Earnings (P/E) Ratio -14.78
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 32.58
Resistance 3 (R3) 32.60 32.06 32.30
Resistance 2 (R2) 32.06 31.63 32.05 32.21
Resistance 1 (R1) 31.48 31.37 31.77 31.46 32.11
Pivot Point 30.94 30.94 31.09 30.93 30.94
Support 1 (S1) 30.36 30.51 30.65 30.34 29.69
Support 2 (S2) 29.82 30.25 29.81 29.59
Support 3 (S3) 29.24 29.82 29.50
Support 4 (S4) 29.22